NASDAQ:GBIO
Generation Bio Co. Stock News
$3.18
-0.170 (-5.07%)
At Close: May 07, 2024
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
06:41pm, Wednesday, 06'th Mar 2024
Generation Bio Co. (GBIO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.55 per share a year ago.
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
06:59am, Tuesday, 27'th Feb 2024
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 03'rd Jan 2024
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced
3 Penny Stocks To Buy According To Insiders In December
03:36pm, Thursday, 07'th Dec 2023
Penny stocks – the cheap stocks trading under $5 per share, offer investors massive upside potential alongside higher risk. Since even incremental price moves translate into huge percentage gains in
Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO)
08:15am, Friday, 20'th Oct 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
07:30am, Thursday, 03'rd Aug 2023
CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
07:30am, Wednesday, 31'st May 2023
CAMBRIDGE, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates
07:45pm, Wednesday, 10'th May 2023
Generation Bio Co. (GBIO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.61 per share a year ago.
Generation Bio to Present at the JMP Securities Life Sciences Conference
04:15pm, Tuesday, 09'th May 2023
CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
07:30am, Tuesday, 11'th Apr 2023
CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announce
Best Penny Stocks To Buy Now? 10 To Watch Under $5
03:03pm, Friday, 24'th Mar 2023
Penny stocks to watch this week under $5 The post Best Penny Stocks To Buy Now? 10 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Penny Stocks To Buy Under $5? 7 To Watch This Week
10:53am, Thursday, 23'rd Mar 2023
Penny stocks to watch under $5 this week. The post Penny Stocks To Buy Under $5?
Generation Bio, Moderna announce collaboration
07:44am, Thursday, 23'rd Mar 2023
Shares of Generation Bio Co. GBIO, -0.51% jumped about 28% premarket trading on Thursday after the company announced a collaboration with Moderna Inc. MRNA, -2.58% to to develop novel nucleic acid the
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
07:30am, Monday, 27'th Feb 2023
CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:30pm, Tuesday, 03'rd Jan 2023
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announce
